These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 24908630
21. PD-1 and its ligands in T-cell immunity. Keir ME, Francisco LM, Sharpe AH. Curr Opin Immunol; 2007 Jun; 19(3):309-14. PubMed ID: 17433872 [Abstract] [Full Text] [Related]
22. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor. Prosser ME, Brown CE, Shami AF, Forman SJ, Jensen MC. Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210 [Abstract] [Full Text] [Related]
23. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Seko Y, Yagita H, Okumura K, Azuma M, Nagai R. Cardiovasc Res; 2007 Jul 01; 75(1):158-67. PubMed ID: 17434153 [Abstract] [Full Text] [Related]
24. Role of PD-1 in regulating T-cell immunity. Jin HT, Ahmed R, Okazaki T. Curr Top Microbiol Immunol; 2011 Jul 01; 350():17-37. PubMed ID: 21061197 [Abstract] [Full Text] [Related]
25. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Oikawa T, Takahashi H, Ishikawa T, Hokari A, Otsuki N, Azuma M, Zeniya M, Tajiri H. Pathol Int; 2007 Aug 01; 57(8):485-92. PubMed ID: 17610472 [Abstract] [Full Text] [Related]
26. Protooncogenes and autoimmunity. Rapoport M, Mor A, Bistritzer T, Ramot Y, Levi O, Slavin S, Wysenbeek A. Isr J Med Sci; 1997 Apr 01; 33(4):262-6. PubMed ID: 9347876 [No Abstract] [Full Text] [Related]
27. Tissue expression of PD-L1 mediates peripheral T cell tolerance. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH. J Exp Med; 2006 Apr 17; 203(4):883-95. PubMed ID: 16606670 [Abstract] [Full Text] [Related]
28. Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer. Calles A, Liao X, Sholl LM, Rodig SJ, Freeman GJ, Butaney M, Lydon C, Dahlberg SE, Hodi FS, Oxnard GR, Jackman DM, Jänne PA. J Thorac Oncol; 2015 Dec 17; 10(12):1726-35. PubMed ID: 26473645 [Abstract] [Full Text] [Related]
29. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis. Concepcion AR, Salas JT, Sáez E, Sarvide S, Ferrer A, Portu A, Uriarte I, Hervás-Stubbs S, Oude Elferink RP, Prieto J, Medina JF. Oncotarget; 2015 Oct 06; 6(30):28588-606. PubMed ID: 26396175 [Abstract] [Full Text] [Related]
30. Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities. Gleisner MA, Reyes P, Alfaro J, Solanes P, Simon V, Crisostomo N, Sauma D, Rosemblatt M, Bono MR. Mol Immunol; 2013 Jul 06; 54(3-4):423-34. PubMed ID: 23428837 [Abstract] [Full Text] [Related]
31. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells. Kaiser AD, Schuster K, Gadiot J, Borkner L, Daebritz H, Schmitt C, Andreesen R, Blank C. Eur J Immunol; 2012 Mar 06; 42(3):662-71. PubMed ID: 22144176 [Abstract] [Full Text] [Related]
32. Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice. Li S, Tajiri K, Murakoshi N, Xu D, Yonebayashi S, Okabe Y, Yuan Z, Feng D, Inoue K, Aonuma K, Shimoda Y, Song Z, Mori H, Huang H, Aonuma K, Ieda M. Int J Mol Sci; 2021 Jan 31; 22(3):. PubMed ID: 33572655 [Abstract] [Full Text] [Related]
33. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells. Chen C, Qu QX, Huang JA, Zhu YB, Ge Y, Wang Q, Zhang XG. Immunobiology; 2007 Jan 31; 212(3):159-65. PubMed ID: 17412283 [Abstract] [Full Text] [Related]
34. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease. Wong M, La Cava A, Singh RP, Hahn BH. J Immunol; 2010 Dec 01; 185(11):6563-71. PubMed ID: 21041733 [Abstract] [Full Text] [Related]
35. PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile. Pizarro C, García-Díaz DF, Codner E, Salas-Pérez F, Carrasco E, Pérez-Bravo F. Diabetes Metab Res Rev; 2014 Nov 01; 30(8):761-6. PubMed ID: 24816853 [Abstract] [Full Text] [Related]
36. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Fife BT, Pauken KE. Ann N Y Acad Sci; 2011 Jan 01; 1217():45-59. PubMed ID: 21276005 [Abstract] [Full Text] [Related]
37. Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells. Martínez VG, Hidalgo L, Valencia J, Hernández-López C, Entrena A, del Amo BG, Zapata AG, Vicente A, Sacedón R, Varas A. Eur J Immunol; 2014 Apr 01; 44(4):1031-8. PubMed ID: 24532425 [Abstract] [Full Text] [Related]
38. Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis. Javan MR, Aslani S, Zamani MR, Rostamnejad J, Asadi M, Farhoodi M, Nicknam MH. Iran J Allergy Asthma Immunol; 2016 Aug 01; 15(4):296-302. PubMed ID: 27921410 [Abstract] [Full Text] [Related]
39. The PD-1-PD-L pathway in immunological tolerance. Okazaki T, Honjo T. Trends Immunol; 2006 Apr 01; 27(4):195-201. PubMed ID: 16500147 [Abstract] [Full Text] [Related]
40. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment. Hassan SS, Akram M, King EC, Dockrell HM, Cliff JM. PLoS One; 2015 Apr 01; 10(9):e0137646. PubMed ID: 26359860 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]